Abstract
This paper describes the hyphenation of cIEF and MALDI-TOF MS via a fractionation or spotting device. After focusing in cIEF the compounds are hydrodynamically mobilized and deposited on a MALDI target plate using a sheath liquid interface, which provides the catholyte solution and the electrical ground. From previous experiments, sample conditions that resulted in a high resolution in cIEF and acceptable protein signal intensity in MS were selected [Silvertand et al., Electrophoresis, 2008, 29, 1985-1996]. Besides the mixture of test proteins, the sample solution contains 1% Pharmalyte, 0.3% hydroxyethyl cellulose and 0.1% Tween 20 and is used for both optimization as well as characterization of the cIEF-MALDI-TOF MS system. Hyphenation problems encountered are mainly due to transfer of the liquid from the needle to the MALDI target plate and are solved by choosing the proper sheath catholyte (200 mM NH(4)OH in 50% methanol with 0.1% Tween20). MS electropherograms were reconstructed by plotting the intensities of the m/z values corresponding to the proteins versus migration time (related to spot number). Reproducibility, peak width and signal intensity for different focusing and spotting (fractionation) times were calculated using these reconstructed MS electropherograms as well as the UV electropherograms. The best results were obtained with focusing time of 75 min (no under- or overfocusing) and a spotting time of 5 s (highest protein signal intensity in MS). The applicability of the system is demonstrated by the analysis of a biopharmaceutical (glucagon) and its deamidation product.
Original language | English |
---|---|
Pages (from-to) | 1828-1835 |
Number of pages | 8 |
Journal | Electrophoresis |
Volume | 30 |
Issue number | 10 |
DOIs | |
Publication status | Published - May 2009 |
Funding
This research is part of the IOP Genomics project "Proteomics on a chip for monitoring auto-immune diseases" and is partly supported by the Netherlands Research Council for Chemical Sciences (NWO/CW) with financial aid from the Netherlands Technology Foundation (STW). The authors also like to thank the group of Prof. Dr. A. J. R. Heck of the Department of Biomolecular Mass Spectrometry (Utrecht University, Utrecht, The Netherlands) and especially Ing. J. M. A. Damen and Dr. N. F. C. Carol-Visser for the use of and help with the MALDI-TOF and for the very useful discussions.
Keywords
- Biopharmaceuticals
- cIEF
- cIEF-UV-MALDI-TOF MS
- MALDI-TOF MS
- Proteins
- FLIGHT MASS-SPECTROMETRY
- FRACTION COLLECTION
- INTACT PROTEINS
- TIME
- DESORPTION/IONIZATION
- ELECTROPHORESIS
- GLUCAGON
- DEAMIDATION
- DEGRADATION
- SEPARATION